PPARγ has been identified in transformed neural cells of human origin, and PPARγ agonists have been shown to decrease cell proliferation, stimulate apoptosis, and induce morphological changes as well as expression of markers typical of a more differentiated phenotype in glioblastoma and astrocytoma cell lines [87–89]. Here, PPARG is linked to astrocytoma (excluding glioblastoma).